Biography

Professor Bo-Göran Ericzon received his MD at the Karolinska Institutet, Stockholm, Sweden, in 1978, and joined the transplant team at the Karolinska Institutet in 1984. Shortly thereafter, Professor Ericzon took a clinical and research fellowship at the University of Pittsburgh, Pennsylvania, PA, USA. In 1993, he earned a Ph D from the Karolinska Institutet with a thesis entitled “Studies on the immunosuppressive and metabolic effects of FK506 in monkey and man”. Since 2000, he has been Professor and Head of the Division of Transplantation Surgery, Department of Clinical Sciences, Intervention and Technology (CLINTEC) at the Karolinska Institutet.
Professor Ericzon’s main research interest is related to liver transplantation for metabolic liver disorders and, in 1990, he became the first in the world to treat familial amyloid polyneuropathy (FAP) with liver transplantation. Another important field of research currently under evaluation is liver transplantation in combination with allogenic bone marrow transplantation for the treatment of advanced cancers. Professor Ericzon’s team also introduced microdialysis as a research and monitoring tool following liver transplantation. Recently, an important focus of research has been hepatocyte transplantation. In 2008, Professor Ericzon’s team performed the first hepatocyte transplantation in Scandinavia.

Professor Ericzon is the author of more than 200 peer-reviewed publications and book chapters, and he is also a member of several international scientific committees. Between 1997 and 1999, he was the president of the European Society of Organ Transplantation (ESOT).